Progyny, Inc.

Progyny, Inc. (NASDAQ: PGNY) specializes in fertility and family building benefits services in the U.S.

Key Highlights

• The company reported YoY growth of 99.15% in total revenue to USD 128.65 million in Q2FY21 (ended June 30, 2021) compared to USD 64.61 million in Q2FY20.
• PGNY reported a net income of USD 18.73 million in Q2FY21 in contrast to a net loss of USD 1.06 million in Q2FY20.
• On May 19, 2021, Welltok partnered with PGNY for its curated and pre-integrated Connect Partner Ecosystem. PGNY's solutions include high-touch member education, support & guidance from Patient Care Advocates, access to fertility specialists, and integrated medical coverage.
• High net margin of 13.5% in FY20 vs. industry median of 4.0%.
• Significantly high ROE of 33.0% in FY20, whereas the industry median stood at 9.7%.
• Stock is currently trading below its 50-day SMA, a crucial short-term support level. On a long-term basis, its current price is close to the 200-day SMA level.
• Stock is currently leaning towards the higher band of the 52-week range of USD 23.56 to USD 66.61.

Technical Price Chart (as of August 09, 2021). Analysis by Kalkine

Conclusion: Considering the significant growth in topline, the surge in net income, and associated risks, we recommend a "Watch" rating on the stock at the closing price of USD 48.22, down 0.08% as of August 09, 2021.

*The reference data in this report has been partly sourced from REFINITIV.

Artisan Partners Asset Management Inc.

Artisan Partners Asset Management Inc. (NYSE: APAM) provides investment management strategies to its clients worldwide. It manages separate equity and fixed income portfolios for its clients.

Key Highlights

• The company reported YoY growth of 50.26% in total revenue to USD 304.95 million in Q2FY21(ended June 30, 2021) compared to USD 202.94 million in Q2FY20.
• Net income for Q2FY21 expanded to USD 88.21 million from USD 46.15 million in Q2FY20.
• On July 12, 2021, APAM announced its Asset Under Management (AUM) amounted to USD 175.21 billion as of June 30, 2021, compared to USD 172.92 billion as of May 31, 2021.
• Significantly high ROE of 43.7% in Q2FY21, whereas the industry median stood at 5.6%.
• Relatively high net margin 39.0% in Q2FY21 vs. industry median of 25.2%.
• Stock is currently trading above its crucial long-term as well as short-term support levels of 50-day and 200-day SMA levels, a bullish indicator.
• Stock is currently leaning towards the higher band of the 52-week range of USD 34.52 to USD 57.65.
• APAM's share price has increased 15.81% and 32.03% in the past nine and twelve months, respectively.

Technical Price Chart (as of August 09, 2021). Analysis by Kalkine

Conclusion: Considering the uptick in the stock price in the past twelve months, the surge in both top and bottom-line, growth in AUM, and associated risks, we recommend a "Watch" rating on the stock at the current price of USD 51.81, up 1.03% as of August 09, 2021, 03:39 PM ET.

*The reference data in this report has been partly sourced from REFINITIV.